The Motley Fool

ISA investors! A top dividend growth stock I’d buy for 2020 and hold for 25 years

Image source: Getty Images.

Assura (LSE: AGR) might not have the storied history of dividend growth as some other London-quoted shares, though this is because it’s only been quoted on London markets since 2015.

But it’s raised the full-year payout every year since and, last time out, by a chubby 8% in the fiscal year. It also looks on course to keep growing rewards for some time too.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

But what makes Assura — which designs, develops and manages primary healthcare facilities the length and breadth of the UK — such a great dividend pick for 2020 in particular, you might ask? A quick look at the company’s share price shows why. The FTSE 250 firm HAS gained 40% in value since the turn of January.

It’s true that a string of positive trading releases in the year to date have whetted share buyers’s appetite. Though, to a large extent, this whopping share price rise pays testament to the defensive appeal of healthcare stocks in tense geopolitical and macroeconomic times as these.

And it’s likely that safe-haven demand will remain solid next year as Brexit rolls on, President Trump’s impeachment proceedings roll on, and Chinese trade wars keep hampering global economic growth.

Help the aged

Right now, though, let me explain why I think Assura is a great buy beyond the next 12 months. Simply put, Britain’s expanding population — and in particular a rapidly-swelling elderly community — means the demand for primary healthcare facilities like GP surgeries is likely to grow and grow.

A recent report from the Office for National Statistics suggests “there are projected to be many more people at older ages” over the next quarter of a century, thanks to a combination of rising life expectations and the 1960s ‘baby boomer’ generation reaching their autumn years. In particular, it expects the number of over-85s to hit 3.2m by 2041, double the number in this age group 25 years earlier.

Obviously, this should continue to put increased strain on the country’s existing network of health clinics and will require many more such units to be built and for widescale regeneration of existing facilities.

~4% dividend yields

What’s more, Assura is expanding rapidly to capitalise on this fertile environment. It announced it has “had a very active first six months of the reporting year [to March 2020],” the business making nine acquisitions and completing two developments. It plans to maintain this breakneck pace too, with acquisition and development pipelines currently sitting at £65m and £72m, respectively.

No wonder City analysts expect profits to keep ticking higher, with rises of 6% and 8% forecasted for fiscal 2020 and 2021, respectively. And, as I said at the top of the piece, this leads to predictions of more dividend growth, resulting in annual yields of 3.8% for this year and 3.9% for next.

Sure there’s bigger yields out there. But I reckon the prospect of bumper dividend cheques as earnings and payouts steadily grow still makes Assura a hot income share to buy today.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.